Back to calendar
NervGen Pharma Corp. (NGEN) Earnings
NGEN reports earnings on Thursday, November 12, 2026
earnings report
November 12, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.10
Actual EPS: $-0.27
EPS surprise: -338.06%
Company overview
Market Cap$156.6M
PriceUSD 1.46
EPS (TTM)-0.40
52-week high6.30
52-week low1.44
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees8